Yalcin Kendal, Degertekin Halil, Yildiz Fetin, Celik Yusuf
Division of Hepatology, Dicle University School of Medicine, Diyarbakir, Turkey.
Clin Invest Med. 2003 Feb;26(1):27-34.
Assessment of disease activity is important in the management of chronic hepatitis B virus (HBV) infection. Our objective was to study the correlation between serum HBV DNA levels and HBV e antigen (HBeAg) status, alanine aminotransferase (ALT) levels, histologic activity, age and sex in patients who had chronic HBV, with emphasis on those who were HBeAg negative with high replication but had normal or below-normal liver enzyme levels and mild liver disease.
At our university-affiliated tertiary care medical centre in Turkey, we studied prospectively 179 consecutive patients who were long-term hepatitis B surface antigen carriers. These patients were first separated into 2 groups according to HBeAg positivity and then subdivided into 4 groups according to the presence of HBV DNA, HBeAg status and ALT levels. The clinical, virologic and histologic differences in these patients were evaluated with respect to the HBeAg status.
Of the 179 patients, 120 (67%) were HBeAg positive and 59 (33%) were HBeAg negative. The mean (and standard deviation) age in the former group was 24.8 (7.60) and in the latter group was 32.2 (11.2) years (p < 0.001). HBeAg-negative patients had significantly more severe liver disease, more male predominance and lower serum HBV DNA levels than HBeAg-positive patients (p < 0.05). HBeAg status had a close correlation with age. There was a significant correlation between age and serum HBV DNA levels but not between HBV DNA levels and disease activity in study groups. We found that some of anti-HBe-positive patients had below-normal ALT levels with minimal or absent histologic changes despite high viral replication.
Monitoring of ALT is of value in assessing hepatocellular damage in patients with chronic hepatitis B virus infection. HBeAg-negative patients with elevated ALT levels and some with normal ALT levels should be considered highly infectious in the course of chronic HBV infection.
疾病活动度评估在慢性乙型肝炎病毒(HBV)感染的管理中很重要。我们的目的是研究慢性HBV患者血清HBV DNA水平与HBV e抗原(HBeAg)状态、丙氨酸氨基转移酶(ALT)水平、组织学活动度、年龄和性别的相关性,重点关注那些HBeAg阴性但病毒复制高且肝酶水平正常或低于正常以及肝病较轻的患者。
在我们位于土耳其的大学附属三级医疗中心,我们前瞻性地研究了179例连续的长期乙型肝炎表面抗原携带者。这些患者首先根据HBeAg阳性情况分为2组,然后根据HBV DNA的存在情况、HBeAg状态和ALT水平再细分为4组。根据HBeAg状态评估这些患者的临床、病毒学和组织学差异。
179例患者中,120例(67%)HBeAg阳性,59例(33%)HBeAg阴性。前一组的平均(及标准差)年龄为24.8(7.60)岁,后一组为32.2(11.2)岁(p<0.001)。HBeAg阴性患者比HBeAg阳性患者有更严重的肝病、男性占比更高且血清HBV DNA水平更低(p<0.05)。HBeAg状态与年龄密切相关。研究组中年龄与血清HBV DNA水平之间存在显著相关性,但HBV DNA水平与疾病活动度之间无相关性。我们发现一些抗-HBe阳性患者尽管病毒复制高,但ALT水平低于正常,组织学改变轻微或无改变。
监测ALT对评估慢性乙型肝炎病毒感染患者的肝细胞损伤有价值。ALT水平升高的HBeAg阴性患者以及一些ALT水平正常的患者在慢性HBV感染过程中应被视为具有高度传染性。